Antibacterial use and Streptococcus pneumoniae penicillin resistance:: A temporal relationship model

被引:20
作者
Mera, Robertino M.
Miller, Linda A.
White, Anthony
机构
[1] Louisiana State Univ, Hlth Sci Ctr, New Orleans, LA USA
[2] GlaxoSmithKline, Collegeville, PA USA
关键词
D O I
10.1089/mdr.2006.12.158
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
The nature of the temporal relationship between antibacterial consumption and Streptococcus pneumoniae penicillin resistance is investigated using population level data across time. IMS Health Global Services provided national outpatient antibiotic prescription data for the years 1996-2003 from France, Spain, Italy, Germany, the United Kingdom, and the United States. Surveillance data consist of S. pneumoniae isolates obtained from a surveillance database in the same geographic regions from 1996 to 2003. A linear mixed model for repeated measures was used to analyze the association between resistance and several antibacterial classes through time. Changes in penicillin resistance through time in any country are better explained by the weighted cumulative antibacterial consumption with a 2-year lag. Narrow-spectrum penicillins are associated with lower resistance rates. Large reductions in consumption at the population level are needed to affect resistance. There is a peak level of penicillin resistance associated with cumulative exposure to a combination of antibiotic classes that is unique for every country.
引用
收藏
页码:158 / 163
页数:6
相关论文
共 23 条
[1]   Antibiotic selection pressure and resistance in Streptococcus pneumoniae and Streptococcus pyogenes [J].
Albrich, WC ;
Monnet, DL ;
Harbarth, S .
EMERGING INFECTIOUS DISEASES, 2004, 10 (03) :514-517
[2]   Evolving resistance patterns of Streptococcus pneumoniae:: A link with long-acting macrolide consumption? [J].
Baquero, F .
JOURNAL OF CHEMOTHERAPY, 1999, 11 :35-43
[4]   A European study on the relationship between antimicrobial use and antimicrobial resistance [J].
Bronzwaer, SLAM ;
Cars, O ;
Buchholz, U ;
Mölstad, S ;
Goettsch, W ;
Veldhuijzen, IK ;
Kool, JL ;
Sprenger, MJW ;
Degener, JE .
EMERGING INFECTIOUS DISEASES, 2002, 8 (03) :278-282
[5]   Antimicrobial-drug use and changes in resistance in Streptococcus pneumoniae [J].
Diekema, DJ ;
Brueggemann, AB ;
Doern, GV .
EMERGING INFECTIOUS DISEASES, 2000, 6 (05) :552-556
[6]   Importance of local variations in antibiotic consumption and geographical differences of erythromycin and penicillin resistance in Streptococcus pneumoniae [J].
García-Rey, C ;
Aguilar, L ;
Baquero, F ;
Casal, J ;
Dal-Ré, R .
JOURNAL OF CLINICAL MICROBIOLOGY, 2002, 40 (01) :159-164
[7]   Outpatient antibiotic use in Europe and association with resistance: a cross-national database study. [J].
Goossens, H ;
Ferech, M ;
Stichele, RV ;
Elseviers, M .
LANCET, 2005, 365 (9459) :579-587
[8]   Streptococcus pneunoniae resistance to erythromycin and penicillin in relation to macrolide and β-lactam consumption in Spain (1979-1997) [J].
Granizo, JJ ;
Aguilar, L ;
Casal, J ;
García-Rey, C ;
Dal-Ré, R ;
Baquero, F .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2000, 46 (05) :767-773
[9]   Streptococcus pneumoniae in vitro development of resistance to amoxicillin/clavulanic acid, cefaclor, levofloxacin and azithromycin [J].
Koeth, LM ;
Good, CE ;
Saunders, KA ;
Jakielaszek, C .
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2004, 24 (02) :144-149
[10]  
Kristinsson KG, 1998, 38 INT C ANT AG CHEM